Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002.

National Center on Birth Defects and Developmental Disabilities, CDC, USA.
MMWR. Surveillance summaries: Morbidity and mortality weekly report. Surveillance summaries / CDC 03/2007; 56(1):29-40.
Source: PubMed

ABSTRACT Autism spectrum disorders (ASDs) encompass a spectrum of conditions, including autistic disorder; pervasive developmental disorders, not otherwise specified (PDD-NOS); and Asperger disorder. Impairments associated with ASDs can range from mild to severe. In 2000, in response to increasing public heath concern regarding ASDs, CDC established the Autism and Developmental Disabilities Monitoring (ADDM) Network. The primary objective of this ongoing surveillance system is to track the prevalence and characteristics of ASDs in the United States. ADDM data are useful to understand the prevalence of ASDs and have implications for improved identification, health and education service planning, and intervention for children with ASDs. Because complete, valid, timely, and representative prevalence estimates are essential to inform public health responses to ASDs, evaluating the effectiveness and efficiency of the ADDM methodology is needed to determine how well these methods meet the network's objective.
The ADDM Network is a multiple-source, population-based, active system for monitoring ASDs and other developmental disabilities. In 2002, data were collected from 14 collaborative sites. This report describes an evaluation conducted using guidelines established by CDC for evaluating public health surveillance systems and is based on examination of the following characteristics of the ADDM Network surveillance system: simplicity, flexibility, data quality, acceptability, representativeness, sensitivity, predictive value positive (PVP), timeliness, stability, data confidentiality and security, and sources of variability.
Using multiple sources for case ascertainment strengthens the system's representativeness, sensitivity, and flexibility, and the clinician review process aims to bolster PVP. Sensitivity and PVP are difficult to measure, but the ADDM methodology provides the best possible estimate currently available of prevalence of ASDs without conducting complete population screening and diagnostic clinical case confirmation. Although the system is dependent on the quality and availability of information in evaluation records, extensive quality control and data cleaning protocols and missing records assessments ensure the most accurate reflection of the records reviewed. Maintaining timeliness remains a challenge with this complex methodology, and continuous effort is needed to improve timeliness and simplicity without sacrificing data quality. The most difficult influences to assess are the effects of changes in diagnostic and treatment practices, service provision, and community awareness. Information sharing through education and outreach with site-specific stakeholders is the best mechanism for understanding the current climate in the community with respect to changes in service provision and public policy related to ASDs, which can affect prevalence estimates.
These evaluation results and descriptions can be used to help interpret the ADDM Network 2002 surveillance year data and can serve as a model for other public health surveillance systems, especially those designed to monitor the prevalence of complex disorders.

  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is rapidly becoming apparent that many E. coli pathotypes cause a considerable burden of human disease. Surveillance of these organisms is difficult because there are few or no simple, rapid methods for detecting and differentiating the different pathotypes. MALDI-TOF mass spectroscopy has recently been rapidly and enthusiastically adopted by many clinical laboratories as a diagnostic method because of its high throughput, relatively low cost, and adaptability to the laboratory workflow. To determine whether the method could be adapted for E. coli pathotype differentiation the Bruker Biotyper methodology and a second methodology adapted from the scientific literature were tested on isolates representing eight distinct pathotypes and two other groups of E. coli. A total of 136 isolates was used for this study. Results confirmed that the Bruker Biotyper methodology that included extraction of proteins from bacterial cells was capable of identifying E. coli isolates from all pathotypes to the species level and, furthermore, that the Bruker extraction and MALDI-TOF MS with the evaluation criteria developed in this work was effective for differentiating most pathotypes.
    Journal of microbiological methods 06/2013; 94(3). DOI:10.1016/j.mimet.2013.06.020 · 2.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: There has been a great interest in tracking health-related fitness across the United States. The NFL PLAY 60 FITNESSGRAM Partnership Project (NFL P60FGPP) is a large participatory research network that involves the surveillance of fitness among more than 1000 schools spread throughout the country. Fitness data are collected by school staff and therefore these data can vary in quality and representativeness. Therefore, careful screening procedures are needed to ensure that the data can reflect actual patterns in the schools. This study examined the impact of different data screening procedures on outcomes of aerobic fitness (AF) collected from the NFL P60FGPP. Methods: Data were compiled from 149,101 youth from 504 schools and were processed using the established age-and gender-specific AF FITNESSGRAM health-related standards. Data were subjected to three different screening procedures (based on grade size and boy-to-girl ratio per grade). Linear models were computed to obtain unadjusted and adjusted (for age, BMI-Z, and socio-economic status) estimates of % youth in the Healthy Fitness Zone (HFZ) in order to determine if, 1) there were differences in % in the HFZ and 2) if differences could be explained by changes in the representativeness of the sample due to the different data screening procedures. Results: Depending on the screening procedure used, the final sample ranged from 96,999 (no screening) to 46,572 youth (most stringent criteria). The proportion of youth achieving appropriate levels of AF ranged from 56% to 61% with unscreened data resulting in consistently lower percentages of youth achieving the standard (P < 0.05). Overall, these differences were not explained by possible changes in demographic characteristics as the result of applying different screening criteria. Conclusions: The findings demonstrate the importance of establishing appropriate screening procedures that maximize sample size while also ensuring generalizability of the findings.
    Open Journal of Preventive Medicine 11/2014; 4(4):876-886. DOI:10.4236/ojpm.2014.411099